Cargando…
Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2
Currently, human infections with the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are accelerating the ongoing spread of the pandemic. Several innovative types of vaccines have already been developed, whereas effective options of antiviral treatments still await a scientific imp...
Autores principales: | Hahn, Friedrich, Häge, Sigrun, Herrmann, Alexandra, Wangen, Christina, Kicuntod, Jintawee, Jungnickl, Doris, Tillmanns, Julia, Müller, Regina, Fraedrich, Kirsten, Überla, Klaus, Kohlhof, Hella, Ensser, Armin, Marschall, Manfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466411/ https://www.ncbi.nlm.nih.gov/pubmed/34578109 http://dx.doi.org/10.3390/pathogens10091076 |
Ejemplares similares
-
The Oligomeric Assemblies of Cytomegalovirus Core Nuclear Egress Proteins Are Associated with Host Kinases and Show Sensitivity to Antiviral Kinase Inhibitors
por: Kicuntod, Jintawee, et al.
Publicado: (2022) -
Exploring the Human Cytomegalovirus Core Nuclear Egress Complex as a Novel Antiviral Target: A New Type of Small Molecule Inhibitors
por: Alkhashrom, Sewar, et al.
Publicado: (2021) -
Properties of Oligomeric Interaction of the Cytomegalovirus Core Nuclear Egress Complex (NEC) and Its Sensitivity to an NEC Inhibitory Small Molecule
por: Kicuntod, Jintawee, et al.
Publicado: (2021) -
Assessment of Covalently Binding Warhead Compounds in the Validation of the Cytomegalovirus Nuclear Egress Complex as an Antiviral Target
por: Tillmanns, Julia, et al.
Publicado: (2023) -
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro
por: Hahn, Friedrich, et al.
Publicado: (2020)